{Etokimab: A Deep Investigation into the 2022981-44-6 Protein Etokimab, designated by the unique identifier 2022981-44-6, represents a groundbreaking immunoglobulin currently in therapeutic evaluation. This biologic https://www.targetmol.com/compound/etokimab